Preventive Cardiology: Ayurveda View
Abhijit Dinkarro Shekhar1, Gunvant H Yeola2, Prasad N Kulkarni3,
Prashant Khade3, Pranesh Gaikwad3
1Assistant Professor, Department of Kayachikitsa, Dr. D Y Patil College of Ayurved and Research Centre, Pune
Dr. D Y Patil Deemed to be University (DPU).
2Principal and HOD, Department of Kayachikitsa, Dr.D Y Patil College of Ayurved and Research Centre, Pune
Dr. D Y Patil Deemed to be University (DPU).
3Associate Professor, Department of Panchakarma, Dr.D Y Patil College of Ayurved and Research Centre, Pune
Dr. D Y Patil Deemed to be University (DPU).
*Corresponding Author E-mail: abhijitshekhar00@gmail.com, gunvantayurved@gmail.com, prasad.kulkarni@dpu.edu.in, prashant.khade@dpu.edu.in, pranesh.gaikwad@dpu.edu.in, abhijitshekhar00@gmail.com
ABSTRACT:
Cardiovascular diseases are one of the leading causes of morbidity and mortality all over the world than any other aliment. The global burden of this disease is gradually increased and it’s about 25% out of the total deaths (2.3 million). The Global Burden of Disease study estimate of age-standardized CVD death rate of 272 per 100 000 population in India is higher than the global average of 235 per 100 000 population. Ayurveda, the art of living and the science of life is serving the man kind since antiquity. However Ayurveda extends itself to accommodate prevention and cure of the diseases which are the major impediments to health, wellbeing and long life. Ayurveda has real strength in promotive and preventive health care through Ahara-Vihara.In view of the increasing evidence of cardiac disorders in the present times this aspect assumes added importance. The present article undertakes to discuss this point in detail, based on Ayurvedic concepts as well as for primary and secondary prevention, rehabilitation and adjunct therapy complementary to conventional treatment for current knowledge.
KEYWORDS: CVD, Preventive health care, Ayurveda, Asana, Pranayama.
INTRODUCTION:
Since the early 1900s, atherosclerotic cardiovascular disease (CVD), including both coronary heart disease (CHD) and stroke, has been the leading cause of death in industrialized nations1. Atherosclerosis represents a unique public health challenge because it is a progressive, lifelong disease that is modified by behavior and yet produces few symptoms until late into its course. Unfortunately, in spite of these efforts, smoking, hypertension, and hypercholesterolemia remain unacceptably common in the general population today.
The global INTERHEART study suggest that nine modifiable risk factors for CVD —dyslipidemia, smoking, diabetes mellitus, hypertension, abdominal obesity, psychosocial stress, poor diet, physical inactivity, and alcohol consumption— account for more than 90% of the risk for CVD2. Success in preventive cardiology is defined by reduction in rates of mortality from CVD and the prevention of nonfatal CVD events3.
The Major Levels Of Prevention Of CVD3 -
|
TABLE 1– |
Level of Prevention |
||
|
Characteristic |
Primordial |
Primary |
Secondary |
|
Target patients |
All patients, including children |
Patients at increased risk for CVD |
Patients with known CVD |
|
Setting Community |
societal Outpatient Inpatient transitioning to outpatient |
Setting Community |
societal Outpatient Inpatient transitioning to outpatient |
|
Delivery of care |
Dietary patterns Policy decisions Education campaigns Environment |
Education campaigns Behavioral intervention Medications |
Environment Medications Rehabilitation |
|
Advantages |
Intervention before risk factors develop Sustainable Does not require screening |
Directed at higher risk individuals Does not require screening Tailored therapy Patients motivated to implement changes |
Directed at highest risk individuals Tailored therapy Patients highly motivated to implement Changes |
|
Disadvantages |
Difficult to implement Hard to quantify effect Up-front costs Individual risk reduction small |
Requires screening of population May delay but not prevent disease “Medicalization” of asymptomatic individuals |
Small segment of population eligible Attempts to attenuate loss of quality of life Not sustainable |
|
Risk Factor |
Goal |
Recommendation |
|
Smoking |
Complete smoking cessation |
Assessment, counseling, and pharmacotherapy |
|
Blood pressure* |
<140/90 mm Hg <130/85 mm Hg if patient has CRI or CHF <130/80 mm Hg if patient has diabetes |
Lifestyle therapy, then individualized pharmacotherapy based on patient characteristics |
|
Diet |
Overall healthy eating pattern |
Consistent with AHA Diet and Lifestyle Guidelines |
|
Aspirin |
Low-dose aspirin in patients with ≥10% 10-year risk |
Doses 75-162 mg/day Contraindicated if patient has risk of GI or otherhemorrhage |
|
Lipid management |
Primary Goal LDL-C level <160 mg/dL if ≤1 RF LDL-C level <130 mg/dL if ≥2 RFs LDL-C level <100 mg/dL if 10-year CHD risk >20% Secondary Goal If triglyceride levels ≥200 mg/dL, then Non–HDL-C level <190 mg/dL if ≤1 RF Non–HDL-C level <160 mg/dL if ≥2 RFs Non–HDL-C level <130 mg/dL if 10-year CHD risk >20% Other Targets Triglyceride levels <150 mg/dL HDL-C level >40 mg/dL in men HDL-C level >50 mg/dL in women NCEP Optional Goals: LDL-C level <100 mg/dL if ≥2 RFs LDL-C level <70 mg/dL if 10-year risk >20% Non–HDL-C level <130 mg/dL if ≥2 RFs Non–HDL-C level <100 mg/dL if 10-year CHD risk >20% |
Lifestyle change, including dietary plant stanols/sterols, viscous fiber, and omega-3 fatty acids Then add statin therapy |
|
Physical activity |
≥30 min activity of moderate intensity per day most days of week |
Additional benefits are obtained from vigorous intensity activity |
|
Weight management |
Primary Goal Achieve BMI of 18.5-24.9 kg/m2 Secondary Goal Waist circumference: <40 inches in men <35 inches in women |
Reduce body weight by 10% in first year of therapy |
|
Diabetes |
Normal fasting glucose HbA1c level < 7% |
· Lifestyle therapy · Oral hypoglycemic agents · Then insulin therapy |
|
Chronic atrial fibrillation |
Normal sinus rhythm or INR of 2.0-3.0 |
Aspirin, 325 mg, can be alternative if patient has high risk of Bleeding |
The current management scenario have its own limitations and drugs which are used they have adverse effects on continuous use. Hence, there is need to detect safe and effective management for CVD’s. Ayurveda science having a major role to play. In samhitagranthas, Hridroga with its aetiopathogenesis as well as management is explained in detail4. Various factors such as dietary, lack of exercise, various psychological factors, krimi etc are the etiological which play important role in the development of these disease.
Hridroga
NIDANA of Hridroga- Hridroga(heart diseae) is caused by following factors-
1) Aahar- Usna, Guru, Kasaya, Tiktasevana, Advasana
2) Somatic factors- Srama, Vegadharana, Abhigata, Ativerechana
3) Psychological factors - Cinta, Bhava, Trasa, Mada
Vagbhata states that the etiological factors of Hridroga are similar to that of Gulma. Modern medicine on the other hand, based on clinical and experimental evidence puts the blame on food containing large amounts of saturated fat,cholesterol, smoking, alcohol consumption, mental stress, lack of exercise, obesity and present sedentarylife style. But Ayurveda describes guru ahara but not singdhaahara i.e. fat containg diet among the causativefactors. ButAcharya describes number of preparations are made with ghrita.
Ahara-It is the most important pillar of human health anddiseaseIn preventive cardiology, the aim of a healthy diet is to provide adequate calories and provide essential nutrients for the individual body requirements. The energy intake should be limited up to maintain BMI 25 kg/m2. For intake of fats, recommendation is that they should account for 30%< of total energy intake, of which saturated fats should contribute 10%< (up to one-third of total fat intake) with remainder being met by intake of polyunsaturated (sunflower oil, soya oil, walnuts, fish oils, etc.) or mono-unsaturated fats (olive,rapeseed oil, nuts and seeds). However, the relationship of saturated fats with CVD is still debated, and there is emerging evidence that those from dairy products may be beneficial.Trans unsaturatedfats, particularly industrially hydrogenated oils (Vanaspati ghee, margarine, etc.) are strongly linked with CVD and should be best avoided or account for 10% < of energy intake. Daily intake of 5-6 portionsof fruitand vegetables (each portion of about 8 gm) is highly recommended. Consumption of 3 -45 gm of fiber is recommended mainly from wholegrain products besides fruit and vegetables. Daily salt intake of 6 gm/ day is recommended.
Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India New Delhi suggested diet chart according to the prakruti of persons,There are three dosha, mixed prakrutis. Following are diet charts to avoids CVD risks5.
Diet Chart for Vata Prakriti Purush –
|
Meal/ time |
Menu |
Quantity |
|
Early morning |
Nuts - Almond Walnuts Lemon tea / Green Tea/ Light tea with milk |
6-7 1-2 1 cup (200 ml.approx.) |
|
Breakfast |
Fruits- Apple/Anar/ Banana Daliya /Cornflakes / poha / upma / oat meal Milk and milk products Idli / dosa |
1 nos. 1 bowl 250 ml 2-3 nos. |
|
Lunch |
Roti Boiled Brown rice with starch Lunch Green vegetable (Lauki,Tinda, Torai, cabbage, Spinach etc.) Mudga Dal (Preferably whole legume) Takra (Butter milk) or Skimmed Curd Apple/Anar/ any citrus fruit |
2-3 nos 1 bowl
1 bowl
1bowl
|
|
Evening |
Fruits-,Papaya, Guava ,Pineapple Roasted chana /Dhokala |
1 nos./ bowl 1 bowl |
|
Dinner |
Roti /Green vegetable (Lauki, Tinda, Torai, Cabbage, Methi, Cauliflower, Spinach etc.) Paneer /Dal Salad (Carrot, Tomato, cucumber, Ginger, Amalakietc). |
1-2 nos 1 bowl
|
|
Bed Time |
Milk |
250ml |
Diet Chart for Pitta Prakriti Purush-
|
Meal/ time |
Menu |
Quantity |
|
Early morning |
Nuts - Almond Kharjura Milk and coconut water. |
6-7 1-2 1 cup (200 ml.approx.) |
|
Breakfast |
Fruits- Apple/Anar/ Banana Daliya / poha / upma / Idli / dosa |
1 nos. 1 bowl 2-3 nos. |
|
Lunch |
Roti Boiled Brown rice with starch Green vegetable (Lauki,Tinda, Torai, cabbage, Spinach etc.Mudga Dal (Preferably whole legume) Takra (Butter milk) or Skimmed Curd |
2-3 nos 1 bowl 1 bowl 1bowl
|
|
Evening |
Fruits-Apple/ Papaya/ Anar/ Guava /Citrus Fruit/ Pineapple Roasted chana /corn Dhokala / murmurachat |
1 nos./ bowl 1 Bowl |
|
Dinner |
Roti / Green vegetable (Lauki,Tinda, Torai, cabbage, Spinach etc.) Paneer /Dal |
1-2 nos 1 bowl 1 bowl 1 bowl
|
|
Bed Time |
Milk |
250 ml |
Diet Chart for Kapha Prakriti Purush-
|
Meal/ time |
Menu |
Quantity |
|
Early morning |
Nuts - Almond or Walnuts Honey Lemon with warm water / coffee / lemon tea |
6-7 1-2 1 cup (200 ml.approx.) |
|
Breakfast |
Fruits- Apple/Anar/ any citrus fruit Besancheela / Vegetable stuffed Roti / Cornflakes with milk / poha/ upama Idali/ dosa |
1 nos. 1 bowl 2-3 nos. |
|
Lunch |
Roti / multi grain roti Boiled Brown rice with starch Green vegetable (Lauki,Tinda, Torai, cabbage, Methi, Bathua,Spinach etc.) Paneer /Dal - Chana and mudga dal (Preferably whole legume) |
2-3 nos 1 bowl 1 bowl 1bowl |
|
Evening |
Fruits- Apple, Anar, any citrus fruit, Papaya, Guava, Pineapple Roasted chana |
1 nos./ bowl 1 Bowl |
|
Dinner |
Roti / Green vegetable (Lauki,Tinda, Torai, cabbage, Methi, Spinach etc.) Paneer /Dal |
1-2 nos 1 bowl |
|
Bed Time |
Milk |
250 ml |
Psychosocial factors:
Ayurveda recognisedthe close relationship between heart and psychological stress. Anxiety, depression, stress at work place, low socio-economic status are the risk of developing and worsening CVD,Above factors also impact on life style of the persons so avoid this simple questionnaires in the form of cognitive-behaviour therapy methods is encouraged which makes a friendly and positive interaction with the patient, understanding their worries and concerns, Ayurved and alternate sciences suggested yoga and Pranayam to avoid the risk of CVD
Yoga And Pranayama- following asanas will be suggested
|
Asanas |
|
Asanas |
|
1.Tadasana (Mountain pose) |
2.Vrikshasana (Tree pose) |
3. UtthitaHastapadasana (Extended hands and feet pose) |
|
4. Trikonasana (Triangle pose) |
5. Veerabhadrasana (Warrior pose) |
6. Utkatasana (Chair pose) |
|
|
8. AdhoMukhoSvanasana |
|
|
|
|
|
Pranayama- Useful in cardiac diseases.
|
Sr.no |
Name |
Duration- |
|
1 |
Bhastrika Pranayama |
Practice daily for 5-6 minutes. |
|
2 |
Kapalbhati Pranayama |
Practice daily for 5-6 minutes. |
|
3 |
AnulomVilom Pranayama |
Practice daily for 5-6 minutes. |
|
4 |
NadiShodhan |
Practice daily for 5-6 minutes |
|
5 |
Bhramari Pranayama |
Practice daily for 3 to 5 minutes. |
1. Meditation- daily Pray for 15-20 minutes in the morning between 4am-8am along with proper instructions.
2. Exercise-45 minutes per day walk for 5days per week
CONCLUSION:
With the rapidly increasing incidence of CVD in developing countries such as India with worsening profile of risk factors, Ayurveda has much to contribute to the prevention of these conditions. A simplified guideline combining Ayurveda and Yoga with a message for a healthy diet, exercise, and mental health for the population would go a long way in CVD prevention. Atherosclerotic CVD is an ideal scenario for prevention efforts because it is a common disease; it is modifiable by behavior; the disease latency is long; the time between symptom onset and severe disability or sudden cardiac death is short; and no cure exists for systemic atherosclerosis once it is present. The majority of improvement in rates of mortality from CVD since the 1960s is the result of prevention, not treatment, of acute CVD. Preventive cardiology must continue across all three levels (primordial, primary, and secondary) with a balance between the two main approaches to prevention (population-based and individual-based). Despite available guidelines, there is a wide gap between the burden of CVD and current preventive efforts6.
ACKNOWLEDGEMENTS:
I would like to thank, Dr YeolaGunvant Principal and professor of Kayachikitsa Department, Dr.D.Y.Paril College of Ayurveda research center,Pimpri Pune and Dr Amit Sinkar Senior Cardiologist in Pune for his help and guidance, particularly with reference to Ayurvedic and Yoga viwes in cardiovascular disease.
REFERENCES:
1. Prof. (Dr.) Abhimanyu Kumar Director General Dr. M. M. Padhi Deputy Director (Technical) Dr. A. Narayana Director, NIIMH Working Group Dr. N. Srikanth Assistant Director (Ayurveda) Dr. B. Venkateshwarlu Research Officer (Ayurveda) Dr. V. Sridevi Research Officer (Ayurveda) Dr. T. Saketh Ram Research Officer (Ayurveda) Dr. K. Bharathi Research Officer (Ayurveda) Dr. G. P. Prasad Research Officer (Ayurveda) Dr. Sobaran Singh Research Officer (Ayurveda) Dr. Shruti Khanduri Research Officer (Ayurveda) Dr. S. C. Verma Research Officer (Chemistry) Central Council for Research in Ayurvedic Sciences Ministry of AYUSH Government of India New Delhi 2015 Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India New Delhi. ISBN : 978-93-83864-31-7
2. WHO. World Health Organization NCD and Global Monitoring Framework. 2 11(1E 1E2 14).
3. JBS3. Joint British Societies consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart 1 (Suppl 2):ii1-ii67 (2 14).
4. Sharma, R.K, Dash, B, Carak Samhita Sutra-sthana, a critical exposition based on Cakrapani Dattas Ayurveda Dipika. English translation,Chapter ( 3-13), Chowkhamba Sanskrit Series ,Varanasi, 2 4
5. Rastogi, S. Ayurvedic Science of Food and Nutrition 3-14 (Springer, 2 14).
6. Perk, Jet al. J european and guidelines on cardiovascular disease prevention in clinical practice (version 2 12). The Fifth joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Our Heart j33:1635-17 1 (2 12).
Received on 09.07.2021 Modified on 19.12.2021
Accepted on 25.03.2022 © RJPT All right reserved
Research J. Pharm. and Tech 2022; 15(11):5368-5372.
DOI: 10.52711/0974-360X.2022.00905